1. Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019; 18:684–696.
2. Hur J, Lee KH, Hong SR, Suh YJ, Hong YJ, Lee HJ, et al. Prognostic value of coronary computed tomography angiography in stroke patients. Atherosclerosis. 2015; 238:271–277.
3. Tanaka H, Sueyoshi K, Nishino M, Ishida M, Fukunaga R, Abe H. Silent brain infarction and coronary artery disease in Japanese patients. Arch Neurol. 1993; 50:706–709.
4. Rincon F, Wright CB. Current pathophysiological concepts in cerebral small vessel disease. Front Aging Neurosci. 2014; 6:24.
5. Lee JE, Shin DW, Yun JM, Kim SH, Nam YS, Cho B, et al. Insulin resistance is a risk factor for silent lacunar infarction. Stroke. 2016; 47:2938–2944.
6. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12:822–838.
7. Nam KW, Kwon HM, Jeong HY, Park JH, Kim SH, Jeong SM, et al. Cerebral white matter hyperintensity is associated with intracranial atherosclerosis in a healthy population. Atherosclerosis. 2017; 265:179–183.
8. Padwal R, Straus SE, McAlister FA. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ. 2001; 322:977–980.
9. Vichova T, Motovska Z. Oxidative stress: predictive marker for coronary artery disease. Exp Clin Cardiol. 2013; 18:e88–e91.
10. Fanning JP, Wesley AJ, Wong AA, Fraser JF. Emerging spectra of silent brain infarction. Stroke. 2014; 45:3461–3471.